Creative Price To Sales Ratio from 2010 to 2025
| CELZ Stock | USD 4.97 0.08 1.58% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 648.92 | Current Value 681.36 | Quarterly Volatility 226.6614561 |
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.7 M, Other Operating Expenses of 6.8 M or Total Operating Expenses of 6.8 M, as well as many indicators such as Price To Sales Ratio of 681, Dividend Yield of 0.0039 or PTB Ratio of 0.76. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
Creative | Price To Sales Ratio |
Latest Creative Medical's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Creative Medical Technology over the last few years. Price to Sales Ratio is figured by comparing Creative Medical Tec stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Creative Medical sales, a figure that is much harder to manipulate than other Creative Medical Technology multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Creative Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 829.42 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Creative Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 304.34 | |
| Geometric Mean | 179.33 | |
| Coefficient Of Variation | 74.48 | |
| Mean Deviation | 160.69 | |
| Median | 322.73 | |
| Standard Deviation | 226.66 | |
| Sample Variance | 51,375 | |
| Range | 718 | |
| R-Value | 0.22 | |
| Mean Square Error | 52,368 | |
| R-Squared | 0.05 | |
| Significance | 0.41 | |
| Slope | 10.50 | |
| Total Sum of Squares | 770,631 |
Creative Price To Sales Ratio History
About Creative Medical Financial Statements
Creative Medical investors use historical fundamental indicators, such as Creative Medical's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 648.92 | 681.36 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.